✦ LIBER ✦

Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial

✍ Scribed by J. Pedersen-Bjergaard; N.I. Nissen; H. Brincker; J. Ellegaard; A. Drivsholm; L. Freund; K.B. Jensen; M. Krogh Jensen

Book ID: 114790679
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 32 KB
Volume: 38
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1987.tb00023.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Daunorubicin versus aclarubicin in combi

Daunorubicin versus aclarubicin in combination with cytarabine and thioguanine in elderly patients with acute nonlymphocytic leukemia, a preliminary report

✍ Magnus Björkholm; Andreas Killander; Leukemia Group of Middle Sweden (LGMS) 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB

Homoharringtonine in combination with cy

Homoharringtonine in combination with cytarabine and aclarubicin in the treatment of refractory/relapsed acute myeloid leukemia: a single-center experience

✍ Wenjuan Yu, Liping Mao, Jiejing Qian, Wenbin Qian, Haitao Meng… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 280 KB

A randomised clinical trial comparing id

A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia

✍ Mandelli, Franco; Petti, Maria C.; Ardia, Alfredo; Di Pietro, Nicola; Di Raimond 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 793 KB

Aclarubicin in the treatment of relapsed

Aclarubicin in the treatment of relapsed or resistant acute myelogenous leukaemia: a phase II trial

✍ S. A. Evensen; F. Wisøff; E. Müller; I. Talstad; A. Waage; L. Johansen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

Phase I–II trial of VP-16 in the treatme

Phase I–II trial of VP-16 in the treatment of acute nonlymphocytic leukemia and blast crisis of chronic granulocytic leukemia

✍ Mailliard, James A. ;Letendre, Louis ;Dalton, Robert J. ;Levitt, Ralph ;Gerstner 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB

VP-16 was used to treat newly diagnosed elderly ( 2 6 5 yr) patients with acute nonlymphocytic leukemia (ANLL) and patients with blast crisis of chronic granulocytic leukemia (BI-CGL). Our pilot study indicated that VP-I6 160 mg/m2 intravenously daily for 5 days was well tolerated and suggested a di

Combination of aclarubicin and etoposide

Combination of aclarubicin and etoposide for the treatment of advanced acute myeloid leukemia: results of a prospective multicenter phase II trial

✍ Kern, W; Braess, J; Grote-Metke, A; Kuse, H; Fuchs, R; Hossfeld, D K; Reichle, A 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 72 KB